CHEBI:89785 - DG(20:3(5Z,8Z,11Z)/20:3(8Z,11Z,14Z)/0:0)

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name DG(20:3(5Z,8Z,11Z)/20:3(8Z,11Z,14Z)/0:0)
ChEBI ID CHEBI:89785
Stars This entity has been manually annotated by a third party.
Supplier Information
Download Molfile XML SDF
Formula C43H72O5
Net Charge 0
Average Mass 669.030
Monoisotopic Mass 668.53798
InChI InChI=1S/C43H72O5/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-35-37-42(45)47-40-41(39-44)48-43(46)38-36-34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h12,14,17-20,23-26,29,31,41,44H,3-11,13,15-16,21-22,27-28,30,32-40H2,1-2H3/b14-12-,19-17-,20-18-,25-23-,26-24-,31-29-/t41-/m0/s1
InChIKey CUMKGQFYKIGEIE-SKHAEIFUSA-N
SMILES O(C[C@](CO)(OC(CCCCCC/C=C\C/C=C\C/C=C\CCCCC)=O)[H])C(CCC/C=C\C/C=C\C/C=C\CCCCCCCC)=O
Metabolite of Species Details
Homo sapiens (NCBI:txid9606) Found in blood (UBERON:0000178). See: PubMed
Roles Classification
Biological Role(s): Saccharomyces cerevisiae metabolite
Any fungal metabolite produced during a metabolic reaction in Baker's yeast (Saccharomyces cerevisiae ).
(via diglyceride )
human metabolite
Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
(via diglyceride )
View more via ChEBI Ontology
ChEBI Ontology
Outgoing DG(20:3(5Z,8Z,11Z)/20:3(8Z,11Z,14Z)/0:0) (CHEBI:89785) is a diglyceride (CHEBI:18035)
Synonyms Sources
(2S)-3-hydroxy-2-[(8Z,11Z,14Z)-icosa-8,11,14-trienoyloxy]propyl (5Z,8Z,11Z)-icosa-5,8,11-trienoate HMDB
1-Meadoyl-2-homo-g-linolenoyl-sn-glycerol HMDB
1-Meadoyl-2-homo-gamma-linolenoyl-sn-glycerol HMDB
DAG(20:3/20:3) HMDB
DAG(20:3n9/20:3n6) HMDB
DAG(20:3w9/20:3w6) HMDB
DAG(40:6) HMDB
DG(20:3/20:3) HMDB
DG(20:3n9/20:3n6) HMDB
DG(20:3w9/20:3w6) HMDB
DG(40:6) HMDB
Diacylglycerol HMDB
Diacylglycerol(20:3/20:3) HMDB
Diacylglycerol(20:3n9/20:3n6) HMDB
Diacylglycerol(20:3w9/20:3w6) HMDB
Diacylglycerol(40:6) HMDB
Diglyceride HMDB
Manual Xref Database
HMDB0007459 HMDB
View more database links
Citation Waiting for Citations Type Source
20671299 PubMed citation Europe PMC